Rossby Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Rossby Financial’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$433	Hold	25	–	–	﹤0.01%	2041
2026 Q1	$318	Buy	+25	New	+$336	﹤0.01%	2151

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Rossby Financial's AMRX Position: Q2 2026 in Review

Rossby Financial held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 25 shares worth $433. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

Rossby Financial first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Rossby Financial held 25 shares of Amneal Pharmaceuticals worth $433 as of Q2 2026.
Rossby Financial left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #2041 holding.
Rossby Financial first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.